|
Schlusskurs
Andere Börsenplätze
|
||
| - USD | - |
|
| 05.08. | PFIZER INC. : Rothschild & Co Redburn-Empfehlung weiterhin neutral | ZM |
| 05.08. | Mercks Keytruda erhält in Kanada Zulassung zur Behandlung von muskelinvasivem Blasenkrebs | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.86% | -3.32% | -3.63% | +18.30% | +8.86% | +52.73% | +160.26% | +342.81% | +1’334.36% | 1’043 Mrd. | |
| +1.04% | -2.99% | -2.07% | +14.21% | +24.47% | +50.87% | +52.38% | +48.30% | +107.33% | 621 Mrd. | |
| +0.98% | -6.49% | -5.70% | +19.45% | +7.75% | +24.00% | +66.66% | +113.86% | +270.00% | 435 Mrd. | |
| +0.43% | +3.74% | +10.49% | +13.89% | +11.70% | +47.47% | +38.42% | +3.78% | +48.30% | 361 Mrd. | |
| +0.79% | -1.06% | +0.27% | +8.47% | +14.45% | +35.80% | +39.61% | +50.23% | +55.15% | 293 Mrd. | |
| -0.37% | -5.60% | -14.84% | -11.49% | -12.93% | +8.62% | +10.30% | +47.20% | +131.35% | 251 Mrd. | |
| +4.57% | +5.21% | +9.00% | +23.74% | +24.60% | +35.91% | +67.64% | +74.29% | +134.84% | 220 Mrd. | |
| +1.35% | -10.00% | -7.26% | +1.64% | -8.44% | +2.87% | -45.43% | -4.99% | +87.30% | 201 Mrd. | |
| -2.58% | -0.73% | +0.37% | -1.29% | +7.35% | +17.16% | +67.46% | +90.13% | +63.86% | 164 Mrd. | |
| +1.57% | +2.62% | +6.13% | -2.42% | +3.65% | +4.28% | -26.30% | -42.72% | -27.17% | 147 Mrd. | |
| -3.43% | +0.84% | +9.46% | +11.73% | +17.96% | +38.78% | +5.19% | -7.00% | +0.55% | 130 Mrd. | |
| +1.28% | +0.31% | -8.18% | +14.25% | +6.94% | +29.29% | +42.40% | +138.84% | +373.33% | 123 Mrd. | |
| +0.76% | -0.46% | -2.62% | +2.99% | +5.84% | +40.64% | +42.80% | +7.55% | -7.94% | 103 Mrd. | |
| +0.44% | +2.83% | +0.43% | +0.25% | -9.54% | -6.08% | -20.62% | -13.24% | +3.57% | 103 Mrd. | |
| +1.14% | -4.34% | -10.30% | -16.44% | -17.94% | -8.75% | +61.93% | +69.06% | +462.11% | 69.83 Mrd. | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66 Mrd. | |
| -0.24% | +1.75% | -3.69% | +27.99% | +33.18% | +97.36% | -5.88% | +4.83% | -48.66% | 55.83 Mrd. | |
| +2.96% | -5.12% | -1.67% | +2.17% | +12.20% | +27.98% | +24.06% | +49.53% | +15.57% | 53.39 Mrd. | |
| +0.22% | -0.65% | -1.67% | -0.63% | -10.12% | -14.06% | +30.36% | -4.05% | +229.14% | 52.37 Mrd. | |
| Durchschnitt | +0.78% | -2.96% | -1.42% | +7.04% | +6.67% | +26.94% | +33.96% | +53.80% | +179.61% | 236.35 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.81% | -3.40% | -1.59% | +11.31% | +9.49% | +35.36% | +64.32% | +115.66% | +403.06% |
- Börse
- Aktien
- 852009 Aktie
- Aktie
- Sektor Pfizer Inc
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
